India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like Red Lion Controls announces Crimson version 3.1 October 25, 2019 Latest Production Tech: BISTel Fault Detection, Pepperl+Fuchs Photoelectric Sensors & More July 5, 2018 Video: Industry Insights from the CEO of igus Inc. January 26, 2018
Latest Production Tech: BISTel Fault Detection, Pepperl+Fuchs Photoelectric Sensors & More July 5, 2018